Live Breaking News & Updates on Pharma Knoll

Stay updated with breaking news from Pharma knoll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

APEIRON Biologics Announces Changes to Management and Supervisory Boards


APEIRON Biologics Announces Changes to Management and Supervisory Boards
DGAP-News: APEIRON Biologics AG
/ Key word(s): Personnel
01.06.2021 / 10:00
APEIRON Biologics Announces Changes to Management and Supervisory Boards
Management Board to be expanded by Romana Gugenberger, PhD, as Chief Medical & Scientific Officer (CMSO) and Andreas Gerber, PhD, as Chief Operating Officer (COO)
Prof. Josef Penninger moves from the Supervisory Board to the newly created Scientific Advisory Board, which he will build up and lead as Chairman
APEIRON to propose Ulrich Granzer PhD as new member of the Supervisory Board at the upcoming Annual General Meeting
Vienna, Austria, 1 June 2021: APEIRON Biologics AG, a privately held biotechnology company developing novel immunotherapies for cancer and respiratory diseases, today announced changes to the Company s Management and Supervisory Boards. ....

Andreas Gerber , Merck Sharpe Dohme , Andreas Jungfer , Edward Charles , Rainer Burian , Julia Hofmann , Josef Penninger , Ulrich Granzer , Manfred Reichl , Romana Gugenberger , Fed Charles , Pharma Knoll , Peter Llewellyn Davies , Pharma Ltd , Mc Services , Bayer Ag , University Of St , Company Management , University Of Basel , Distribution Services , Company Supervisory Board , Granzer Regulatory Consulting Services , Research Development Department , Head Of Research Development , University Of Vienna , Announces Changes ,